Overview

Gender

male

Charles Sawyers has been a member of the Board of
Directors since 2013. He qualifies as an independent Non-Executive
Director. He is a member of the Research & Development
Committee and the Governance, Nomination and Corporate
Responsibilities Committee.

In the United States Sawyers is chair of the Human Oncology
and Pathogenesis Program at Memorial Sloan-Kettering Cancer
Center, professor of medicine and of cell and developmental
biology at the Weill Cornell Graduate School of Medical Sciences,
and an investigator at the Howard Hughes Medical Institute. He
serves on US President Barack Obama’s National Cancer Advisory
Board and is past president of the American Association of Cancer
Research and former president of the American Society for Clinical
Investigation. He also is a member of the US National Academy of
Sciences and Institute of Medicine.

Sawyers received his M.D. from the Johns Hopkins School of
Medicine in the United States, and worked at the Jonsson
Comprehensive Cancer Center at the University of California, Los
Angeles, for nearly 18 years before joining Memorial SloanKettering
in 2006. An internationally acclaimed cancer researcher,
he co-developed the Novartis cancer drug Gleevec/Glivec, and has
received numerous honors and awards, including the LaskerDeBakey
Clinical Medical Research Award in
2009.

Sawyers is a member of the Scientific Advisory Board of
Agios Pharmaceuticals, Inc. in the United States.